Rimexolone
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a606003 |
| Pregnancy category |
|
| Routes of administration |
Eye drops |
| ATC code | H02AB12 (WHO) S01BA13 (WHO) |
| Identifiers | |
|
|
| Synonyms | Trimexolone; Org 6216; 11β-Hydroxy-16α,17α,21-trimethylpregna-1,4-dien-3,20-dione |
| CAS Number | 49697-38-3  |
| PubChem (CID) | 5311412 |
| IUPHAR/BPS | 7099 |
| DrugBank | DB00896 |
| ChemSpider | 4470902  |
| UNII | O7M2E4264D |
| KEGG | D05729 |
| ChEMBL | CHEMBL1200617 |
| ECHA InfoCard | 100.211.227 |
| Chemical and physical data | |
| Formula | C24H34O3 |
| Molar mass | 370.525 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.[2]
References[edit]
- ^ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol. 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.
- ^ Haberfeld, H, ed. (2015). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag.
 |
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
